Aim: To investigate whether phase II cardiac rehabilitation (CR) conducted by a community model of shared care CR (SC-CR) including health care centres and general practice was feasible and provided acceptable results and to compare
Introduction
Multifactorial cardiac rehabilitation (CR) in ischaemic heart disease has a proven benefit on survival, on risk of cardiovascular death, on adherence to drug therapy, and on lifestyle modification. 1, 2 CR is recommended for all patients after acute coronary syndrome (ACS) (myocardial infarction and unstable angina pectoris) with stable angina, with heart failure, and after bypass or valvular surgery. However, not all patients are systematically offered or referred to CR. Frequently reported barriers for referral and attending CR programmes were logistics due to the distance to the CR centre, patients' beliefs that they could handle their own problems, and simply a lack of time. 3, 4 After discharge, phase II CR has been carried out in hospital outpatient clinics, after which the general practitioner (GP) takes over secondary prevention from phase III. In Denmark, CR is financed from taxes and is hence free of charge, and transportation times are generally short. Despite these favourable circumstances, adherence to CR does not appear to be higher in Denmark than in other countries (i.e. 50-79%). 5, 6 Primary care providers have now been made more responsible than they previously were for the education, control, and treatment of patients with chronic diseases (Danish Health Reform Act of 2007). The GPs are supported in this task by the newly established public Municipal Health Care Centres (MHCCs). In the MHCCs, patients with chronic diseases, including heart disease referred from a GP, are encouraged to adopt lifestyle modification through programmes involving exercise, smoking cessation, health education, and nutrition.
The aim of this study was to establish a phase II model of shared care CR (SC-CR) between hospitals, GP, and municipalities and to compare adherence and efficacy concerning risk factor management and pharmacological treatment in SC-CR with hospital-based CR (H-CR) after ACS in a randomised controlled trial.
Materials and methods

Trial design
The study was designed as an open 1:1 randomised controlled trial for comparing H-CR with SC-CR. Detailed information on the trial protocol has previously been published. 7 
Participants
Patients who were hospitalised due to ACS in the four coronary units within Aarhus University Hospital, the Central Hospital Unit, Viborg, and Silkeborg Regional Hospitals were screened by study nurses. Eligible patients were informed before discharge by the cardiologist and enrolled in the trial by the study nurses. Interventions SC-CR. In SC-CR, the GP played a more prominent role in phase II CR than in the hospital-based model, but with the same level of lifestyle moderating being offered, as seen in Figure 1 . Details on the components of SC-CR are shown in Table 1 . The first visit was in the outpatient clinic at 1-2 weeks after discharge. A specialised nurse and a cardiologist conducted a clinical assessment, and a Watt max bike exercise test was performed. Then, the patient was referred to the GP. Individualised optimal treatment goals were noted on each patient's chart by the cardiologist, including targets for blood pressure, cholesterol, and body mass index (BMI)/weight. This information was communicated to the GP as part of the discharge document. Risk factor management and pharmacological treatment were then managed by the GP. All patients were encouraged to consult their GP a few weeks after discharge, and again at the end of the phase II CR programme. The discharge chart was also made available to the MHCC, which provided courses on smoking cessation, nutrition, and exercise training and contributed to disease education and psychosocial support. The patient was contacted by the MHCC (by phone or letter), and an individual meeting was scheduled as an introduction to the MHCC CR programme.
H-CR. The H-CR was performed entirely within hospital outpatient clinics, as seen in Figure 1 . Details on the components of H-CR are shown in Table 2 . The H-CR programme terminated with a consultation with a cardiologist concerning risk factors and future medication. A discharge note was then sent to the GP, who took over future risk factor management from phase III of the CR. Further details have been published in the protocol article.
Outcomes
The primary outcome was defined as adherence to the CR programme, measured as a composite of the participation in the different components of the programme 8 : Efficacy was evaluated by changes in the listed secondary outcomes: 24-hour ambulatory blood pressure measurement, weight, abdominal circumference, cholesterol levels, fasting blood glucose, haemoglobin A1C, prescribed cardiovascular medicine, and compliance with lifestyle modifications.
Sample size
Using Danish Heart Association data, we hypothesised that SC-CR would improve the rate of full attendance by 20% up to 55%. 9 This was considered realistic because a previous Danish study reported that 58.5% of all patients participated fully or partially in the CR component of health education at the hospital. 5 The expected sample size of 208 participants would enable us to identify such an increase in the attendance rate with a power of 0.80 and a two-sided p-value of <0.05. The proportion of patients who dropped out or withdrew was expected to be 10%.
Randomisation
Computer randomisation was performed after consent was obtained, stratified by hospital and municipality, ensuring an equal distribution of H-CR and SC-CR in each hospital. Blinding was not possible.
Ethical considerations
The study was conducted in accordance with good clinical practice and the ethical standards described in the Helsinki Declaration. The Central Denmark Region Committees on Biomedical Research Ethics j.nr. M-20110135 and the Danish Data Protection Agency approved the study protocol j.nr. 2011-41-6533, which was changed to 2014-41-3342 in 2014.
Statistical analysis
Data analysis was performed according to the intention-totreat principal. Patients leaving the trial due to medical reasons at the first rehabilitation visit were censored as excluded. Patients withdrawing from the study before the baseline visit were censored as withdrawals. Patients lost to follow-up were censored as dropouts. Comparison of the SC-CR and H-CR groups in the primary endpoint of full adherence to CR was analysed using relative risk with 95% confidence intervals (CIs). In the efficacy evaluation, changes in the secondary outcomes were analysed by Student's paired t-tests when data were parametrically distributed. Non-parametric data were analysed by Wilcoxon signed rank test. Data analysis was performed in STATA 12.1.
Results
Inclusion lasted from 10 October 2011 to 24 March 2013. Four-month follow-up occurred between 2 February 2012 and 31 August 2013 as soon as phase 2 CR was completed, or 5 months after admission if CR was delayed or if a bypass operation was needed. One patient experienced a rupture of the Achilles tendon during exercise; otherwise, no major events were reported throughout the trial. The trial flowchart is shown in Figure 2 . Table 3 shows patient baseline characteristics at the time of randomisation. Women constituted 25% of the patients, forming 21% in H-CR and 29% in SC-CR (p = 0.09). The mean transportation time between the home and the rehabilitation facility to the MHCC was 19 minutes (range: 4-150) and to the hospitals was 26 minutes (range 5-120) (p = 0.54).
Adherence to phase II CR is shown in Table 4 . No difference was seen in terms of full adherence to the combined CR programme (SC-CR vs. H-CR, RR: 0.98, 95% CI: 0.73-1.32). Adherence to the individual components of the programmes varied. Adherence rates to dietary advice (RR: 0.61, 95% CI: 0.46-0.80) and health education (RR: 0.63, 95% CI: 0.48-0.83) were significantly lower in the SC-CR arm. In SC-CR, risk factor evaluation and clinical assessment at the end of CR were to be performed by the GP; however, 12% did not attend, whereas all patients in H-CR attended the evaluation and clinical assessment by the cardiologist at the hospital. Exercise training was declined by approximately 25% of the patients in both groups. Table 5 shows the percentages of patients achieving the recommended treatment targets and the prescribed cardiovascular medicine at discharge, at the end of phase II CR, and at 12 months after ACS. No differences were found regarding total cholesterol, low-density lipoprotein cholesterol, daily exercise, blood pressure, smoking status, waist circumference, or BMI. Overall, the percentage of patients achieving the target blood pressure seemed to decline from baseline to follow-up, but while an increasing percentage of patients in SC-CR achieved the recommended blood pressure target, the percentage was decreasing in H-CR. In general, all patients were treated with statins and aspirin, and most were also given a second platelet inhibitor. Approximately 80% received a beta-blocker. Close to a third had a renin-angiotensin-aldosterone system (RAAS) inhibitor prescribed. At the end of phase II, CR RAAS inhibition increased in both groups to approximately 40%. At 12 months after ACS, adherence to statins was significantly higher in H-CR, but otherwise only small differences were observed.
Discussion
The shared care model did not improve the adherence to and efficacy of the SC-CR programme compared with H-CR, which was our primary outcome, but we found no indication that SC-CR was not safe. In the H-CR arm, significantly more patients had risk factor evaluation, dietary advice, and clinical assessment performed at the end of CR. Adherence to dietary advice and health education was better in H-CR. Several participants in both treatment arms chose not to take part in exercise training.
CR adherence was similar to the adherence rates reported in other trials. 3, 6, 10 One of the main differences in the two CR models was the location of the rehabilitation facilities. However, the median difference in transportation time between the hospital and the MHCC turned out to be too small for evaluating a superior effect of transportation time on adherence.
Achievement of lifestyle targets seemed difficult to obtain, which corresponds to the findings from the EUROASPIRE IV survey. 11 Chow et al. found that a benefit from adherence to behavioural advice (smoking, diet, and exercise) was seen after 6 months. 2 The finding of smoking cessation in approximately 50% is similar to that which has been found in other studies; however, the percentage fulfilling the recommendation of 30 minutes of exercise on ⩾5 days a week declined in both groups during the phase II CR period. Similar effects have been reported previously. 12 Recently, a dose-response relationship between the number of CR sessions attended and mortality was reported, and long-term survival benefits in patients joining a comprehensive CR programme has also made the effort of increasing adherence to CR even more advantageous, and hence a relevant measure of exercise in particular. 10, 13 However, the shared care model did increase adherence to exercise training.
Adherence to the recommended medication was high, being almost complete to dual antiplatelet therapy and statins and at approximately 80% to beta-blockers. However, only 40% received RAAS inhibition medication. Approximately 80% in a Dutch study and 65% in a French study received this type of medication. 12, 14 Approximately 75% of our patients were normotensive at the first clinical examination. Strangely, the percentage of patients achieving the recommended blood pressure values decreased from baseline to follow-up in H-CR and increased in H-CR. An Austrian study found that 91% achieved the target blood pressure after CR, but this study included heart failure patients. 15 Potentially, the percentage achieving the target blood pressure may have been higher if RAAS inhibitors had been prescribed more aggressively. There is no very obvious explanation for this, but according to the PEACE study, the usefulness of angiotensin-converting enzyme inhibitors in patients with ACS and normal blood pressure is not necessarily very high. 16 Participation in the trial was rejected by 35% of potential candidates. The patients declining to participate had, on average, a higher mean age and more frequently were more women, and the main reason they provided was a lack of surplus energy due to uncertainty related to the randomisation and the possibility of facing a new model of CR. Due to the rejection rate and a sample size of 212, caution must be exerted when generalising our findings. The data did not allow for subgroup analysis of transportation time or comorbidity. The objective of this trial was to evaluate adherence to CR in a new setting with primary care in charge. The trial results could be extrapolated to other hospitals and municipalities in Denmark, since the model is based on exploiting existing resources that are now present in all Danish municipalities, but high attention to inter-sectoral coordination in the CR course is important. A model with nurses coordinating the course between sectors has been described as a useful measure. 17 The Organisation for Economic Co-operation and Development report on Danish Health quality from 2013 emphasises the need for specific quality initiatives focused on coordination between primary and secondary care. 18 This can be accomplished with the SC-CR model. However, the model has to be further developed, and ideas for promoting greater programme adherence and lifestyle modifications are still needed, but the model provides an opportunity to offer CR to a broader group of patients in the local community, hopefully with high-quality and good outcomes for the patients in a health care system, thereby meeting future requirements of quality and productivity at a reduced cost.
Conclusion
We report the first randomised trial investigating whether implementing a shared care programme between the specialised hospital unit, the community-based MHCC and the GP could increase adherence to CR. We succeeded in describing and implementing this type of care sharing, but the shared care model was not associated with improved programme adherence. The achievement of targets for cholesterol, smoking cessation, blood pressure, and other medical therapies was equal just after CR, and SC-CR was found to be safe.
Implications for practice
• • The shared care model of cardiac rehabilitation between the specialised hospital unit, the community-based Municipal Health Care Centre and the general practitioner is described and could be implemented. • • The shared care model was not associated with improved programme adherence compared to hospital-based cardiac rehabilitation. • • The achievement of targets for cholesterol, smoking cessation, blood pressure, and other medical therapies was equal just after cardiac rehabilitation.
Trial registration: clinicaltrials.gov identifier: NTC 01522001.
